Concepedia

Evaluation of Representation of Women as Authors in Pivotal Trials Supporting US Food and Drug Administration Approval of Novel Cardiovascular Drugs

Izza Shahid, Muhammad Shahzeb Khan, Aruba Sohail, Safi U. Khan, Stephen J. Greene, Marat Fudim, Erin D. Michos

JAMA Network Open · 2022 · 11 citations · 4 references

DOIFull text

Open access

Concepts

Abstract

This cross-sectional study evaluates the representation of women as authors of pivotal trials of novel cardiovascular drugs approved by the US Food and Drug Administration between 2008 and 2020.

References

4

Are gender gaps due to evaluations of the applicant or the science? A natural experiment at a national funding agency

Holly O. Witteman, Michael Hendricks, Sharon E. Straus et al. · The Lancet · 2019 · 560 citations

, , +11

Ten‐Year Trends in Enrollment of Women and Minorities in Pivotal Trials Supporting Recent US Food and Drug Administration Approval of Novel Cardiometabolic Drugs

Muhammad Shahzeb Khan, Izza Shahid, Tariq Jamal Siddiqi et al. · Journal of the American Heart Association · 2020 · 153 citations · Full text

, , +10

Representation of Women Authors in International Heart Failure Guidelines and Contemporary Clinical Trials

Nosheen Reza, Ayman Samman Tahhan, Nadim Mahmud et al. · Circulation Heart Failure · 2020 · 87 citations · Full text

, , +15

Representation of Women in Cardiovascular Clinical Trial Leadership

Kara Denby, Natalie Szpakowski, Julie K. Silver et al. · JAMA Internal Medicine · 2020 · 81 citations · Full text

, , +9